Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials Group.
暂无分享,去创建一个
I. Tannock | L. Seymour | M. Moore | W. Walsh | E. Winquist | N. Murray | S. Huan | K. Bennett | S. Huan
[1] M. Mazumdar,et al. Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] B. Redman,et al. Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] I. Tannock,et al. Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] T. Kuzel,et al. Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] I. Tannock,et al. Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] G. Scagliotti,et al. Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] D. Neuberg,et al. Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] R. Dreicer,et al. Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] A. Ceribelli,et al. Weekly gemcitabine in advanced bladder cancer: a preliminary report from a phase I study. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] I. Tannock,et al. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] L. Hertel,et al. Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine). , 1990, Cancer research.
[12] N. Geller,et al. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse , 1989, Cancer.